These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 19382270

  • 21. [Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity].
    Gervain J, Czibula A, Simon J, Kalmár T.
    Orv Hetil; 2003 Jun 15; 144(24):1179-84. PubMed ID: 12866147
    [Abstract] [Full Text] [Related]

  • 22. Amino acid substitution in HCV core region and genetic variation near the IL28B gene affect viral dynamics during telaprevir, peginterferon and ribavirin treatment.
    Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Chayama K, Nakamura Y, Kumada H.
    Intervirology; 2012 Jun 15; 55(6):417-25. PubMed ID: 21325786
    [Abstract] [Full Text] [Related]

  • 23. Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy.
    Alhamlan FS, Al-Ahdal MN, Khalaf NZ, Abdo AA, Sanai FM, Al-Ashgar HI, Elhefnawi M, Zaid A, Al-Qahtani AA.
    J Med Virol; 2014 Feb 15; 86(2):224-34. PubMed ID: 24166351
    [Abstract] [Full Text] [Related]

  • 24. Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.
    Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Matsuda M, Kobayashi M, Arase Y, Ikeda K, Kumada H.
    Intervirology; 2005 Feb 15; 48(6):372-80. PubMed ID: 16024941
    [Abstract] [Full Text] [Related]

  • 25. Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon.
    Kobayashi M, Watanabe K, Ishigami M, Murase K, Ito H, Ukai K, Yano M, Takagi K, Hattori M, Kakumu S, Yoshioka K.
    Am J Gastroenterol; 2002 Apr 15; 97(4):988-98. PubMed ID: 12003437
    [Abstract] [Full Text] [Related]

  • 26. Amino acid substitutions in the core region associate with insulin resistance in chronic hepatitis C.
    Hung CH, Hu TH, Lee CM, Huang CM, Chen CH, Wang JH, Lu SN.
    Intervirology; 2013 Apr 15; 56(3):166-71. PubMed ID: 23406967
    [Abstract] [Full Text] [Related]

  • 27. Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma.
    Takeyasu M, Akuta N, Suzuki F, Seko Y, Kawamura Y, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H.
    J Med Virol; 2012 Aug 15; 84(8):1199-207. PubMed ID: 22711347
    [Abstract] [Full Text] [Related]

  • 28. Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b.
    Saito T, Ito T, Ishiko H, Yonaha M, Morikawa K, Miyokawa A, Mitamura K.
    Am J Gastroenterol; 2003 Jun 15; 98(6):1377-83. PubMed ID: 12818284
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C, Bruno S, Di Marco V, Di Bona D, Rumi M, Vinci M, Rebucci C, Cividini A, Pizzolanti G, Minola E, Mondelli MU, Colombo M, Pinzello G, Craxì A.
    Hepatology; 2006 Jan 15; 43(1):64-71. PubMed ID: 16374856
    [Abstract] [Full Text] [Related]

  • 33. Sequence variability of HCV Core region: important predictors of HCV induced pathogenesis and viral production.
    Khaliq S, Jahan S, Pervaiz A.
    Infect Genet Evol; 2011 Apr 15; 11(3):543-56. PubMed ID: 21292033
    [Abstract] [Full Text] [Related]

  • 34. Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis.
    Akuta N, Suzuki F, Seko Y, Kawamura Y, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Hara T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H.
    Hepatology; 2012 Dec 15; 56(6):2134-41. PubMed ID: 22806754
    [Abstract] [Full Text] [Related]

  • 35. The efficacy of 24-week interferon monotherapy for type C liver cirrhosis in Japanese patients with genotype 1b and low virus load.
    Arase Y, Suzuki F, Sezaki H, Kawamura Y, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Yatsuji H, Hirakawa M, Kobayashi M, Ikeda K, Kumada H.
    Intervirology; 2008 Dec 15; 51(4):265-9. PubMed ID: 18841028
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment.
    Torres-Puente M, Cuevas JM, Jiménez-Hernández N, Bracho MA, García-Robles I, Carnicer F, del Olmo J, Ortega E, Moya A, González-Candelas F.
    J Med Virol; 2008 Feb 15; 80(2):247-53. PubMed ID: 18098147
    [Abstract] [Full Text] [Related]

  • 37. HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection.
    Hsu SJ, Hsu CS, Liu CH, Liu CJ, Chen CL, Chen PJ, Chen DS, Kao JH.
    Antivir Ther; 2011 Feb 15; 16(2):227-35. PubMed ID: 21447872
    [Abstract] [Full Text] [Related]

  • 38. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L, Capeau J.
    Liver Int; 2009 Mar 15; 29 Suppl 2():13-25. PubMed ID: 19187069
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of amino acid mutation in hepatitis C virus core region among Japanese volunteer blood donors.
    Furui Y, Hoshi Y, Murata K, Ito K, Suzuki K, Uchida S, Satake M, Mizokami M, Tadokoro K.
    J Med Virol; 2011 Nov 15; 83(11):1924-9. PubMed ID: 21915867
    [Abstract] [Full Text] [Related]

  • 40. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S, Cammà C, Di Marco V, Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F, Tarantino G, Marchesini G, Craxì A.
    Am J Gastroenterol; 2008 May 15; 103(5):1136-44. PubMed ID: 18477344
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.